Home » Featured » Page 31
Featured
Emergent BioSolutions Inc. on Monday hosted Maryland Gov. Larry Hogan at the multinational biopharmaceutical company’s East Baltimore, Md., Bayview facility where the Johnson & Johnson COVID-19 vaccine candidate is being manufactured.
Emergent’s Bayview facility, which is designated by... Read More »
The Federal Emergency Management Agency (FEMA) has set aside approximately $1.98 billion to states, tribes, territories as well as Washington D.C., for community vaccination centers.
Currently, there are 175 federally supported vaccine centers operational across the country. The federal... Read More »
New legislation introduced in both chambers of Congress last week -- the Community Immunity During COVID-19 Act -- proposes support for vaccination efforts and to reverse drops in vaccination rates through a mix of funding for local initiatives and access to primary care services.
The effort is... Read More »
Following efficacy and safety data reports released earlier, Johnson & Johnson announced today that Janssen Biotech, Inc. -- J&J’s pharmaceutical arm -- has applied for Emergency Use Authorization from the United States Food and Drug Administration (FDA) for its COVID-19 vaccine candidate.... Read More »
The results of Phase 3 clinical trials of COVID-19 Vaccine AstraZeneca in the United Kingdom, Brazil, and South Africa were released this week in The Lancet, proving the vaccine to be safe and effective, including preventing any severe cases for at least 22 days after the first dose.
All told,... Read More »
U.S. Sen. Elizabeth Warren (D-MA) and Rep. Jan Schakowsky (D-IL) introduced legislation to publicly manufacture personal protective equipment, prescription drugs, and other medical supplies necessary to fight the COVID-19 pandemic.
The Pandemic Emergency Manufacturing Act of 2021 authorizes the... Read More »
Members of the Democrat-controlled U.S. House Energy and Commerce Committee argued Wednesday the Trump administration’s actions on COVID-19 were inadequate to bring the pandemic under control and only the massive expenditure being called for by President Joe Biden will be enough to defeat the... Read More »
The United States Departments of Defense (DoD) and Health and Human Services (HHS) awarded $231.8 million to Ellume USA LLC this week to expand the domestic production capacity of its COVID-19 Home Test.
These funds will increase Ellume’s U.S. production capacity by 640,000 tests per day by... Read More »
A new forecast from the Institute for Health Metrics and Evaluation at the University of Washington establishes the danger of two new variants of COVID-19, warning of the possibility of a surge of deaths later this year, even despite the vaccine rollout.
According to the report, B.1.351 -- the... Read More »
Novavax, Inc. demonstrated a strong showing of its COVID-19 vaccine last week, posting an 89.3 percent efficacy in a United Kingdom-based phase three trial, conducted in partnership with the UK government’s Vaccines Taskforce.
Notably, this vaccine was also pitted against variants of the... Read More »
The results of the phase three ENSEMBLE clinical trial have shown that Johnson & Johnson’s single-shot Janssen COVID-19 vaccine candidate is 66 percent effective overall at preventing moderate to severe COVID-19 cases 28 days after vaccination.
The study also showed that the vaccine... Read More »
A new agreement between Sanofi and BioNTech grants the latter access to Sanofi’s infrastructure to aid manufacturing of the COVID-19 vaccine BioNTech has co-developed with Pfizer, granting them the ability to make more than 125 million doses for Europe from summer on.
“Although vaccination... Read More »
In new data released by Eli Lilly and Company, a cocktail of neutralizing antibodies bamlanivimab and etesevimab reduced COVID-19 related hospitalizations and deaths by 70 percent among more than 1,000 high-risk patients.
According to the report, which was based on the BLAZE-1 phase three... Read More »
According to a new study by the International Chamber of Commerce Research Foundation, the global economy stands to lose as much as $9.2 trillion if governments fail to ensure developing economy access to COVID-19 vaccines.
The study demonstrates the economic case to invest in the Access to... Read More »
The development and deployment of an effective vaccine for COVID-19 could be the turning point in the fight against the deadly pandemic, and companies involved in the process must make specific business and public health considerations simultaneously to help ensure a successful outcome, experts... Read More »
COVAX announced last week that a new purchase agreement with Pfizer-BioNTech will secure up to 40 million doses of COVID-19 vaccine for rollout, offering the potential to deliver at least 2 billion doses of vaccines, equitably, by year’s end.
“Today marks another milestone for COVAX:... Read More »
In an attempt to address U.S. global health security staffing and to provide a permanent designated official for coordinating interagency health response, 57 House members supported the reintroduction of the Global Health Security Act this week.
Led by U.S. Reps. Gerry Connolly (D-VA), president... Read More »
In a letter to President Joe Biden this week, U.S. Sens. Tammy Baldwin (D-WI) and Chris Murphy (D-CT) led 24 other senators in supporting full use of the Defense Production Act (DPA) to ramp up the production and stockpiling of medical, testing and protective equipment for use in the COVID-19... Read More »
The U.S. Department of Health and Human Services (HHS) will award nearly $20 million in funds from the Coronavirus Aid, Relief, and Economic Security Act (CARES) Act to increase data sharing between health information exchanges and immunization information systems.
“These CARES Act funds will... Read More »
The World Health Organization (WHO) hosted a virtual forum last week to identify knowledge gaps and set research priorities for vaccines against COVID-19.
At the forum – attended by more than 2,800 scientists from 130 countries – the participants discussed the safety and efficacy of existing... Read More »
An indictment was unsealed in Central Islip, N.Y., last week, charging 14 leaders in MS-13 who are known as the Ranfla Nacional, which operated as the organization’s board of directors, directing MS-13’s criminal activity for almost two decades.
The indictment charges the defendants with... Read More »
Last week, a collection of 30 United States Representatives wrote to House and committee leadership to demand the creation of an independent, bipartisan commission to investigate the government’s failure to address domestic terrorism and prevent this month’s assault on the Capitol.
Led by... Read More »
U.S. Sen. Dianne Feinstein (D-CA) is calling on the Centers for Disease Control and Prevention (CDC) to issue guidelines that will maximize vaccine distribution.
In a letter to CDC Director Robert Redfield, Feinstein pointed out that some vaccine providers have reported leftover doses, doses... Read More »
A group of U.S. Senators recently demanded that the Trump administration take immediate action to remedy the COVID-19 vaccine distribution failures.
Specifically, the 43 senators are calling on Health and Human Services (HHS) Secretary Alex Azar to develop and implement a national vaccine plan.... Read More »
The International Coordinating Group (ICG) on Vaccine Provision is creating a global stockpile of the single-dose Merck and Sharp & Dohme Corp. Ebola vaccine to guarantee response capabilities for any outbreak, with financial support from Gavi, the Vaccine Alliance.
The stockpile was deemed... Read More »
Moderna, Inc. will expand its vaccine efforts with three new development programs targeting mRNA vaccines for HIV, Nipah, and four seasonal flu viruses.
The company also intends to expand its respiratory syncytial virus (RSV) vaccine program to older adults.
This is thanks to the... Read More »
The violent suicide bombing that rocked downtown Nashville, Tenn., on Christmas morning and devastated dozens of businesses in the area also exposed the difficulties with an American reliance on reactive, rather than proactive, emergency planning efforts.
While much focus has been placed on... Read More »
The U.S. Department of Health and Human Services (HHS) and Tucson Medical Center (TMC) began administering monoclonal antibody therapeutic treatments last week.
The treatments were given at a temporary COVID-19 infusion center in Tucson. It is just the second federally supported infusion center... Read More »
At least 80 percent to 85 percent of Americans should receive the COVID-19 vaccine for the country to reach herd immunity, said National Institutes of Health Director Francis Collins in a Jan. 6 interview with the Washington Post.
“Herd immunity requires the majority of a population to be... Read More »
Before Jan. 19, 2021, the Centers for Disease Control and Prevention (CDC) will release more than $22 billion in funding to support states, localities, and territories grappling with the COVID-19 pandemic through a mix of expanded testing and vaccination distribution efforts.
"This funding is... Read More »
The National Security Council staff has launched a task force to coordinate the investigation and remediation of the recent Solar Winds cyberattack involving federal government networks.
The task force -- called the Cyber Unified Coordination Group (UCG) -- is composed of representatives from... Read More »
U.S. Reps. Abigail Spanberger (D-VA) and John Katko (R-NY) introduced a bill to enhance the nation’s readiness to prepare for and respond to public safety and national security threats – including pandemics.
Their bill -- the Analyzing Disaster Vulnerabilities and Applicable National... Read More »
U.S. Reps Brian Fitzpatrick (R-PA) and Josh Gottheimer (D-NJ) introduced a bill requiring the regular disclosure of the presence of designated Foreign Terrorist Organizations on social media websites.
Further, the bill, the Online Terrorism Prevention Act (H.R.9043), would impose financial and... Read More »
A peer-reviewed report chronicling the phase three trial data of mRNA-1273, Moderna, Inc.’s COVID-19 vaccine, was released in the New England Journal of Medicine last week and confirmed its 94.1 percent efficacy in preventing COVID-19.
Distribution of the vaccine has already begun in the... Read More »
The first U.S. case of a new strain of COVID-19 that originated in the U.K. has been confirmed in Colorado’s Elbert County, according to the Colorado State Laboratory.
The variant has cropped up in numerous locations throughout the world since its recent discovery -- and rapid spread -- in the... Read More »
